Dianthus Therapeutics, Inc.
|
Price
$105.60
|
Friday
+10.75%
|
30 Day
+25.52%
|
90 Day
+21.49%
|
1 Year
+409.16%
|
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc.
3 Reasons to Watch DNTH
- Phase 3 Trial Launch Could Move The Needle. Dianthus just announced the initiation of its Phase 3 Emerge trial testing claseprubart in generalized myasthenia gravis, which is a serious neuromuscular disease with significant unmet need. This is the kind of late-stage milestone that puts a clinical-stage biotech on the radar of bigger institutional buyers, so watch for volume spikes when trading resumes Monday.
- The Stock Is Already Up 409% In A Year. DNTH closed Friday up over 10% on the session and has now gained more than 409% over the past year, with a 25% pop in just the last 30 days alone. That kind of momentum tends to attract both momentum traders and short sellers, so expect fireworks either way as the week kicks off.
- New Inducement Grants Signal Aggressive Hiring Push. The company filed a Nasdaq Rule 5635(c)(4) inducement grant announcement over the weekend, which typically means Dianthus is bringing on new employees outside of its standard equity plan. Rapid headcount expansion at a clinical-stage biotech often signals the company is scaling up operations ahead of what it expects to be a busy stretch of trial activity.
Larry Benedict generated $274 million for his clients by finding the trade most missed. He says The Final Phase of Elon's Master Plan is about to trigger one of the biggest wealth transfers in market history. He's already identified the ONE ticker positioned to capture it. It isn't SpaceX, Tesla, or anything you'd expect. He's giving away the name, free.
Click here to get the full details before the window closes.Top Market Headlines
Global Oil Supply Is Being Squeezed From Two Directions at Once. Here Are the Best Energy Stocks to Buy.
In a world of rising inflation and commodity prices, identifying the right investment separates the market beaters from the rest.
Read The Full StorySee this Building the Size of Several Football Fields? (Ad)
This is where Elon Musk is housing an AI technology that Jeff Brown believes will help power the next monster IPO on Wall Street. You see, while everyone was distracted by the SpaceX IPO… Elon Musk quietly started backing a NEW AI startup that has been called… "The fastest-growing business in the history of capitalism." And Jeff will also show you how to claim a stake for as little as $50.
Click here to get the name completely free of charge…
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the AlertsThese 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Google Holds Top Rating
Among the best stocks in earnings performance, highly rated Eli Lilly is in a buy zone.
Read The Full StoryJim Cramer Says the Market Is “Dead Wrong” About These 5 Oversold Stocks
On Thursday, July 16, during the broadcast of Mad Money , Jim Cramer pushed back on the market's punishment of several blue-chip companies that jus...
Read The Full StoryAmerica's New AI "Mega Computer" to Span an Area Bigger than the State of Texas (Ad)
The AI boom has been stalled for months. But according to legendary tech investor Louis Navellier, that's about to change. The world's first AI "Mega Computer" — Golden Dawn — will come online in 2026. It will cover a territory larger than the state of Texas… and be more than 1 trillion times more powerful than Elon Musk's Colossus. This company's building it right now.
Click here for the full story.5 Quantum Computing Stocks Set for Huge Price Upside in 2H 2026
Quantum Computing stocks QBTS, RGTI, IONQ, QUBT and QNT lagged in 2026 but carry sizable brokerage upside as U.S.
Read The Full StoryTrump Admin to Pump $1 Billion into this "Off-the-Radar" AI Stock (Ad)
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into MP Materials. The stock popped 200%. It bought 10% of Trilogy Metals. The stock popped 500%. And now, Trump has chosen this AI stock for a $1 billion payday.
Click here for the full story and stock pick (free).📈 Also Trending
Elon Musk could take SpaceX public in 2026, at an estimated $1.75 trillion valuation. The IPO would include Elon's AI model, Grok. But according to Louis Navellier, a radical new AI model will launch this year… over 1,000 times more powerful than Elon's. And the company behind it could outperform Sp...
Click here for full details (including Louis' new pick — free).
One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this...
Watch now…
I checked our download records for "The Big Beautiful Bubble Report" and didn't see your name. That concerns me. With the national debt hitting $38 trillion and growing $8 billion daily, this intelligence report is more critical than ever. But we may have to take it down soon.
Download The Big Beautiful Bubble Report FREE